TT virus (TTV) was the first member of the new family Anelloviridae to be discovered. TTV, for transfusion transmitted virus or torque teno virus was first reported in a Japanese patient in 1997 by the research scientist T. Nishizawa.[1] The virus is extremely common, even in healthy individuals—as much as 100% prevalent in some countries, and in approximately 10% of blood donors in the UK and the US. Although it does not appear to cause symptoms of hepatitis on its own, it is often found in patients with liver disease.[2] For the most part, TTV infection is believed to be asymptomatic.

Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) ELISA Kit employs a two-site sandwich ELISA to quantitate IgG in samples. An antibody specific for IgG has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyIgG present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for IgG is added to the wells. After washing, Streptavidin conjugated Horseradish Peroxidase (HRP) is added to the wells. Following a wash to remove any unbound avidin-enzyme reagent, a substrate solution is added to the wells and color develops in proportion to the amount of IgG bound in the initial step. The color development is stopped and the intensity of the color is measured.

Pig Transfusion transimitted virus/Hepatitis H virus antibody (IgG) ELISA Kit listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Find more details at http://www.abbkine.com/product/pig-transfusion-transimitted-virus-hepatitis-h-virus-antibody-igg-elisa-kit-kte80197/

Abbkine Scientific Co., Ltd. was founded by a number of scientists and marketing experts in the field of life science in California in 2012. With growing demands from Asia Pacific, it move its headquarters to China. Combining cutting edge technology from United States with China's manufacturing engineering and cost advantages, we aim to provide innovative, high quality assay kits, recombinant proteins, antibodies and other research tools to accelerate life science fundamental research, drug discovery, etc.